New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA)

Sickle Cell Retinopathy Clinical Trial

— OCTA  

Official title:

New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA): Sickle Cell Maculopathy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03068702
• Other study ID #: Optical Coherence Tomography
• Status: Completed
• Phase: N/A
• First received: February 22, 2017
• Last updated: March 1, 2017
• Start date: August 21, 2016
• Est. completion date: February 21, 2017

Study information

• Verified date: February 2017
• Source: Dr. S.S. Michel Clinic
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Sickle cell maculopathy was sparingly mentioned in the literature before despite the fact that sickle cell disease or sickle cell trait is common in people of many areas of the world. This study shows that OCTA is a very valuable, non invasive, office procedure that may well be used in diagnosing this disease.

Description:

this is a clinical study of two African Canadian patients that were diagnosed with sickle cell trait. I used OCTA to show macular vascular occlusions that usually happen with this disease.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2
• Est. completion date: February 21, 2017
• Est. primary completion date: January 12, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria: people with sickle cell trait or sickle cell disease -

Exclusion Criteria:

Related Conditions & MeSH terms

• Sickle Cell Retinopathy

Intervention

Device:
• Optical Coherence Tomography Angiography

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Dr. S.S. Michel Clinic

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	vascular changes seen in the macular vasculature of people with sickle cell disease/ trait as compared to macular vasculature of normal macula.	in this angiography the delicate vasculature of the macula can be clearly visualized and documented.	through study completion, an average of one year